Swedbank AB Boosts Stake in Marsh & McLennan Companies, Inc. $MMC

by · The Cerbat Gem

Swedbank AB raised its stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MMCFree Report) by 21.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,093,014 shares of the financial services provider’s stock after acquiring an additional 196,355 shares during the quarter. Swedbank AB owned approximately 0.22% of Marsh & McLennan Companies worth $220,275,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in MMC. Activest Wealth Management grew its stake in Marsh & McLennan Companies by 2,775.0% in the first quarter. Activest Wealth Management now owns 115 shares of the financial services provider’s stock valued at $28,000 after purchasing an additional 111 shares during the last quarter. Headlands Technologies LLC bought a new stake in shares of Marsh & McLennan Companies in the 2nd quarter valued at about $29,000. Westside Investment Management Inc. grew its position in shares of Marsh & McLennan Companies by 363.3% in the 2nd quarter. Westside Investment Management Inc. now owns 139 shares of the financial services provider’s stock worth $30,000 after buying an additional 109 shares during the last quarter. Delos Wealth Advisors LLC purchased a new stake in Marsh & McLennan Companies during the second quarter valued at approximately $32,000. Finally, Access Investment Management LLC acquired a new stake in Marsh & McLennan Companies in the second quarter valued at approximately $39,000. 87.99% of the stock is currently owned by hedge funds and other institutional investors.

Marsh & McLennan Companies Price Performance

Shares of NYSE:MMC opened at $185.90 on Wednesday. Marsh & McLennan Companies, Inc. has a twelve month low of $174.18 and a twelve month high of $248.00. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 1.19. The company has a market cap of $91.08 billion, a PE ratio of 22.29, a price-to-earnings-growth ratio of 3.18 and a beta of 0.75. The company’s 50 day moving average is $183.44 and its 200 day moving average is $199.04.

Marsh & McLennan Companies (NYSE:MMCGet Free Report) last announced its quarterly earnings data on Thursday, October 16th. The financial services provider reported $1.85 EPS for the quarter, beating the consensus estimate of $1.78 by $0.07. Marsh & McLennan Companies had a net margin of 15.60% and a return on equity of 31.79%. The business had revenue of $6.35 billion during the quarter, compared to analysts’ expectations of $6.34 billion. During the same period in the previous year, the business posted $1.63 EPS. The business’s quarterly revenue was up 11.5% compared to the same quarter last year. On average, sell-side analysts forecast that Marsh & McLennan Companies, Inc. will post 9.61 EPS for the current year.

Insiders Place Their Bets

In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 21,079 shares of Marsh & McLennan Companies stock in a transaction dated Monday, December 1st. The stock was sold at an average price of $182.22, for a total transaction of $3,841,015.38. Following the completion of the transaction, the chief executive officer owned 87,681 shares in the company, valued at approximately $15,977,231.82. This trade represents a 19.38% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 0.35% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. Mizuho initiated coverage on Marsh & McLennan Companies in a report on Tuesday, December 16th. They set an “outperform” rating and a $212.00 price objective for the company. JPMorgan Chase & Co. upgraded Marsh & McLennan Companies from a “neutral” rating to an “overweight” rating and decreased their price target for the company from $248.00 to $242.00 in a research note on Thursday, October 9th. Morgan Stanley dropped their price target on Marsh & McLennan Companies from $220.00 to $215.00 and set an “equal weight” rating on the stock in a research note on Tuesday, October 7th. UBS Group decreased their price objective on shares of Marsh & McLennan Companies from $258.00 to $257.00 and set a “buy” rating for the company in a research report on Wednesday, October 8th. Finally, Wolfe Research started coverage on shares of Marsh & McLennan Companies in a research report on Tuesday, September 16th. They set a “peer perform” rating on the stock. Eight investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Marsh & McLennan Companies currently has an average rating of “Hold” and an average target price of $222.35.

View Our Latest Analysis on Marsh & McLennan Companies

About Marsh & McLennan Companies

(Free Report)

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

See Also